Noticeably, besides melanoma, our study showed other cancers benefited from immunotherapy (e.g., cancers of lung, colorectal, kidney, bladder, and head and neck) also exhibited the consistent association of MUC16 mutation with high TML. Here, MUC16 is linked to melanoma.